PMID- 28522783
OWN - NLM
STAT- MEDLINE
DCOM- 20171004
LR  - 20171004
IS  - 2299-2847 (Electronic)
IS  - 0032-373X (Linking)
VI  - 89
IP  - 1
DP  - 2017 Feb 28
TI  - Splenic abcesses as infectious complication following implantation of left 
      ventricular asssist device - case report.
PG  - 61-65
LID - 10.5604/01.3001.0009.6005 [doi]
AB  - Left ventricular assist device (LVAD) is one of the modern management therapies 
      in patients with advanced heart failure, and it serves as a bridge to heart 
      transplantation or even as destination therapy. However, it is burdened with a 
      high risk of thromboembolic, hemorrhagic, and infectious complications despite 
      prophylactic management. Splenic abscesses, as septic complications following 
      implantation of mechanical ventricular support, have not yet been described in 
      the literature. We report of a patient with severe left ventricular insufficiency 
      (NYHA II/III), pulmonary hypertension, and arrhythmia who underwent implantation 
      of the Heart Ware(R) pump for left ventricular support with simultaneous 
      tricuspidvalvoplasty, as a bridge therapy to heart transplantation. During two 
      years after LVAD implantation, the patient had three MRSA skin infections, 
      localized at the exit site of the drive-line connecting the artificial ventricle 
      with external unit, that were complicated by sepsis and treated with 
      broad-spectrum antibiotics. A few months later, abdominal CT revealed two 
      abscesses in the spleen, and the patient was qualified for splenectomy. Open 
      splenectomy was performed under full-dose anticoagulant therapy with continuous 
      intravenous infusions of unfractionated heparin (UFH). The intra- and 
      postoperative course was uneventful. UFH therapy was continued for 6 days, and 
      oral anticoagulation was re-administered on day 4 after surgery. The patient was 
      discharged on day 7 after surgery with primary healed wound. Open splenectomy, 
      performed with full-dose anticoagulant therapy, proved to be an effective and 
      definitive method of treatment without any complications.
FAU - Gajda, Slawomir
AU  - Gajda S
AD  - Klinika Chirurgii Ogolnej, Onkologicznej i Metabolicznej, Instytut Hematologii i 
      Transfuzjologii w Warszawie Kierownik: prof. dr hab. Andrzej B. Szczepanik.
FAU - Szczepanik, Anna M
AU  - Szczepanik AM
AD  - Uniwersytet Jagiellonski Klinika Chorob Wewnetrznych i Geriatrii, Kierownik: 
      prof. dr hab. Tomasz Grodzicki.
FAU - Religa, Grzegorz
AU  - Religa G
AD  - Wojewodzki Specjalistyczny Szpital im. W. Bieganskiego w Lodzi Oddzial 
      Kardiochirurgii, Kierownik: dr Grzegorz Religa.
FAU - Misiak, Andrzej
AU  - Misiak A
AD  - Klinika Chirurgii Ogolnej, Onkologicznej i Metabolicznej, Instytut Hematologii i 
      Transfuzjologii w Warszawie Kierownik: prof. dr hab. Andrzej B. Szczepanik.
FAU - Szczepanik, Andrzej B
AU  - Szczepanik AB
AD  - Klinika Chirurgii Ogolnej, Onkologicznej i Metabolicznej, Instytut Hematologii i 
      Transfuzjologii w Warszawie Kierownik: prof. dr hab. Andrzej B. Szczepanik.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - Poland
TA  - Pol Przegl Chir
JT  - Polski przeglad chirurgiczny
JID - 0376426
SB  - IM
MH  - Drug Resistance, Multiple
MH  - Heart Failure/*surgery
MH  - Heart-Assist Devices/*adverse effects
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Pseudomonas Infections/complications/*diagnosis
MH  - Splenic Diseases/*microbiology/surgery
MH  - Treatment Outcome
OTO - NOTNLM
OT  - infection
OT  - left ventricular assist device (LVAD)
OT  - splenectomy
OT  - splenic abscesses
EDAT- 2017/05/20 06:00
MHDA- 2017/10/05 06:00
CRDT- 2017/05/20 06:00
PHST- 2017/05/20 06:00 [entrez]
PHST- 2017/05/20 06:00 [pubmed]
PHST- 2017/10/05 06:00 [medline]
AID - 01.3001.0009.6005 [pii]
AID - 10.5604/01.3001.0009.6005 [doi]
PST - ppublish
SO  - Pol Przegl Chir. 2017 Feb 28;89(1):61-65. doi: 10.5604/01.3001.0009.6005.